Sabby Management »

Calidi Biotherapeutics shares owned by Sabby Management

Quarter-by-quarter ownership of Calidi Biotherapeutics (CLDI) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Sabby Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $104k 435k 0.24

More positions owned by Sabby Management

Spdr S&p 500 Etf Etf Put Option
Ishares Tr Etf Put Option
Spdr S&p 500 Etf Etf (SPY)
Gevo Put Option
Abivax Sa Ads Call Option
Alphaton Capital Corp SHS (ATON)
Briacell Therapeutics Corp *W
Senestech (SNES)
Big Tree Cloud Hldgs Cl A
Kempharm Put Option
Briacell Therapeutics Corp (BCTX)
Sidus Space Put Option
Token Cat Ads (TC)
Pop Culture Group SHS (CPOP)
Moleculin Biotech (MBRX)

View all positions for Sabby Management

Top funds holding Calidi Biotherapeutics

Armistice Capital
Sabby Management
Warberg Asset Management
HighTower Advisors
Virtu Financial
Geode Capital Management
Rs Crum
SRS Capital Advisors
Jane Street
Vanguard Group
Vanguard Capital Management
Belpointe Asset Management
Northern Trust
Hrt Financial
Farther Finance Advisors

View all funds holding Calidi Biotherapeutics